​
​

Sight Sciences (SGHT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Sight Sciences Revenue Highlights

Latest Revenue (Y)

$81.06M

Latest Revenue (Q)

$20.16M

Main Segment (Y)

Surgical Glaucoma

Sight Sciences Revenue by Period

Sight Sciences Revenue by Year

DateRevenueChange
2023-12-31$81.06M13.63%
2022-12-31$71.33M45.70%
2021-12-31$48.96M77.12%
2020-12-31$27.64M18.38%
2019-12-31$23.35M210.07%
2018-12-31$7.53M-

Sight Sciences generated $81.06M in revenue during NA 2023, up 13.63% compared to the previous quarter, and up 1076.44% compared to the same period a year ago.

Sight Sciences Revenue by Quarter

DateRevenueChange
2024-09-30$20.16M-5.68%
2024-06-30$21.37M10.93%
2024-03-31$19.27M2.74%
2023-12-31$18.75M-6.29%
2023-09-30$20.01M-14.75%
2023-06-30$23.47M24.69%
2023-03-31$18.82M-8.37%
2022-12-31$20.54M9.99%
2022-09-30$18.68M8.40%
2022-06-30$17.23M15.78%
2022-03-31$14.88M1.33%
2021-12-31$14.69M12.09%
2021-09-30$13.10M4.52%
2021-06-30$12.54M45.17%
2021-03-31$8.63M-3.96%
2020-12-31$8.99M3.93%
2020-09-30$8.65M147.03%
2020-06-30$3.50M-46.09%
2020-03-31$6.50M-

Sight Sciences generated $20.16M in revenue during Q3 2024, up -5.68% compared to the previous quarter, and up 85.88% compared to the same period a year ago.

Sight Sciences Revenue Breakdown

Sight Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Dry Eye$6.75M$5.74M$2.46M
Surgical Glaucoma$74.31M$65.59M$46.50M

Sight Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: Surgical Glaucoma (91.68%), and Dry Eye (8.32%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Surgical Glaucoma$18.63M$20.24M$18.26M$17.15M$18.43M$21.40M$17.33M$18.75M$17.07M$15.90M$13.87M$13.92M$12.45M$11.99M
Dry Eye$1.52M$1.13M$1.01M$2.54M$1.58M$1.14M$1.49M$1.79M$1.60M$1.33M$1.01M$762.00K$655.00K$547.00K

Sight Sciences's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Surgical Glaucoma (92.43%), and Dry Eye (7.57%).

Sight Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CNMDCONMED$1.24B$316.70M
VREXVarex Imaging$811.00M$209.10M
AVNSAvanos Medical$673.30M$170.40M
AORTArtivion$354.00M$95.78M
TCMDTactile Systems$274.42M$73.09M
FNAParagon 28$216.39M$61.02M
ANIKAnika Therapeutics$166.66M$38.75M
KIDSOrthoPediatrics$148.73M$52.80M
SIBNSI-BONE$138.89M$40.34M
SGHTSight Sciences$81.06M$20.16M
LUNGPulmonx$68.67M$20.39M
NPCENeuroPace$65.42M$21.06M
CVRXCVRx$39.30M$13.37M
RPIDRapid Micro Biosystems$22.52M$7.60M
OFIXOrthofix Medical$100.00K$198.62M

SGHT Revenue FAQ

What is Sight Sciences’s yearly revenue?

Sight Sciences's yearly revenue for 2023 was $81.06M, representing an increase of 13.63% compared to 2022. The company's yearly revenue for 2022 was $71.33M, representing an increase of 45.70% compared to 2021. SGHT's yearly revenue for 2021 was $48.96M, representing an increase of 77.12% compared to 2020.

What is Sight Sciences’s quarterly revenue?

Sight Sciences's quarterly revenue for Q3 2024 was $20.16M, a -5.68% decrease from the previous quarter (Q2 2024), and a 0.74% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $21.37M, a 10.93% increase from the previous quarter (Q1 2024), and a -8.95% decrease year-over-year (Q2 2023). SGHT's quarterly revenue for Q1 2024 was $19.26M, a 2.74% increase from the previous quarter (Q4 2023), and a 2.34% increase year-over-year (Q1 2023).

What is Sight Sciences’s revenue growth rate?

Sight Sciences's revenue growth rate for the last 3 years (2021-2023) was 65.57%, and for the last 5 years (2019-2023) was 247.16%.

What are Sight Sciences’s revenue streams?

Sight Sciences's revenue streams in c 23 are Dry Eye, and Surgical Glaucoma. Dry Eye generated $6.75M in revenue, accounting 8.32% of the company's total revenue, up 17.59% year-over-year. Surgical Glaucoma generated $74.31M in revenue, accounting 91.68% of the company's total revenue, up 13.29% year-over-year.

What is Sight Sciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Sight Sciences was Surgical Glaucoma. This segment made a revenue of $74.31M, representing 91.68% of the company's total revenue.